A detailed history of Paradigm Capital Management Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 107,300 shares of ATRC stock, worth $3.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
107,300
Previous 107,300 -0.0%
Holding current value
$3.3 Million
Previous $2.44 Million 23.13%
% of portfolio
0.14%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.86 - $29.09 $198,600 - $290,900
10,000 Added 10.28%
107,300 $2.44 Million
Q1 2024

May 15, 2024

BUY
$28.21 - $37.78 $69,114 - $92,561
2,450 Added 2.58%
97,300 $2.96 Million
Q4 2023

Feb 13, 2024

BUY
$32.99 - $43.25 $252,373 - $330,862
7,650 Added 8.77%
94,850 $3.39 Million
Q3 2021

Nov 08, 2021

SELL
$69.28 - $84.46 $6.04 Million - $7.36 Million
-87,200 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$24.49 - $43.84 $2.2 Million - $3.95 Million
-90,000 Reduced 50.79%
87,200 $2.93 Million
Q4 2019

Feb 05, 2020

BUY
$24.06 - $32.51 $120,300 - $162,550
5,000 Added 2.9%
177,200 $5.76 Million
Q3 2019

Nov 07, 2019

BUY
$23.81 - $32.52 $2.5 Million - $3.41 Million
105,000 Added 156.25%
172,200 $4.3 Million
Q2 2019

Aug 08, 2019

BUY
$26.85 - $30.74 $719,580 - $823,832
26,800 Added 66.34%
67,200 $2.01 Million
Q3 2018

Nov 14, 2018

SELL
$27.62 - $35.58 $276,200 - $355,800
-10,000 Reduced 19.84%
40,400 $1.42 Million
Q2 2018

Aug 08, 2018

SELL
$19.65 - $30.28 $1.18 Million - $1.82 Million
-60,000 Reduced 54.35%
50,400 $1.36 Million
Q1 2018

Apr 09, 2018

BUY
$15.05 - $21.03 $1.06 Million - $1.48 Million
70,400 Added 176.0%
110,400 $2.27 Million
Q3 2017

Nov 06, 2017

SELL
$20.0 - $24.23 $18,500 - $22,412
-925 Reduced 2.26%
40,000 $895,000
Q2 2017

Aug 10, 2017

BUY
N/A
40,925
40,925 $992,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.